BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29261789)

  • 1. Consistent expression of guanylyl cyclase-C in primary and metastatic gastrointestinal cancers.
    Danaee H; Kalebic T; Wyant T; Fassan M; Mescoli C; Gao F; Trepicchio WL; Rugge M
    PLoS One; 2017; 12(12):e0189953. PubMed ID: 29261789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.
    Carrithers SL; Barber MT; Biswas S; Parkinson SJ; Park PK; Goldstein SD; Waldman SA
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14827-32. PubMed ID: 8962140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo.
    Gallery M; Zhang J; Bradley DP; Brauer P; Cvet D; Estevam J; Danaee H; Greenfield E; Li P; Manfredi M; Loke HK; Rabino C; Stringer B; Williamson M; Wyant T; Yang J; Zhu Q; Abu-Yousif A; Veiby OP
    PLoS One; 2018; 13(1):e0191046. PubMed ID: 29370189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract.
    Birbe R; Palazzo JP; Walters R; Weinberg D; Schulz S; Waldman SA
    Hum Pathol; 2005 Feb; 36(2):170-9. PubMed ID: 15754294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanylyl cyclase C as a biomarker for targeted imaging and therapy of metastatic colorectal cancer.
    Chang C; Marszlowicz G; Waldman Z; Li P; Snook AE; Lin JE; Schulz S; Waldman SA
    Biomark Med; 2009 Feb; 3(1):33-45. PubMed ID: 20477494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9.
    Lubbe WJ; Zuzga DS; Zhou Z; Fu W; Pelta-Heller J; Muschel RJ; Waldman SA; Pitari GM
    Cancer Res; 2009 Apr; 69(8):3529-36. PubMed ID: 19336567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of guanylyl cyclase C expressed by human colorectal cancer cell lines in vitro.
    Waldman SA; Barber M; Pearlman J; Park J; George R; Parkinson SJ
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):505-14. PubMed ID: 9641495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood guanylyl cyclase c (GCC) expressions are associated with prognostic parameters and response to therapy in colorectal cancer patients.
    Camci C; Sahin A; Sevinc A; Kalender ME; Oztuzcu S; Sever ON; Ozkara E; Demiryürek AT
    Tumour Biol; 2011 Dec; 32(6):1265-70. PubMed ID: 21901559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.
    Flickinger JC; Rappaport JA; Barton JR; Baybutt TR; Pattison AM; Snook AE; Waldman SA
    Biomark Med; 2021 Feb; 15(3):201-217. PubMed ID: 33470843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A splice variant of the transcript for guanylyl cyclase C is expressed in human colon and colorectal cancer cells.
    Pearlman JM; Prawer SP; Barber MT; Parkinson SJ; Schulz S; Park J; Zook M; Waldman SA
    Dig Dis Sci; 2000 Feb; 45(2):298-305. PubMed ID: 10711442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C.
    Almhanna K; Wright D; Mercade TM; Van Laethem JL; Gracian AC; Guillen-Ponce C; Faris J; Lopez CM; Hubner RA; Bendell J; Bols A; Feliu J; Starling N; Enzinger P; Mahalingham D; Messersmith W; Yang H; Fasanmade A; Danaee H; Kalebic T
    Invest New Drugs; 2017 Oct; 35(5):634-641. PubMed ID: 28527133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.
    Frick GS; Pitari GM; Weinberg DS; Hyslop T; Schulz S; Waldman SA
    Expert Rev Mol Diagn; 2005 Sep; 5(5):701-13. PubMed ID: 16149873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.
    Schulz S; Hyslop T; Haaf J; Bonaccorso C; Nielsen K; Witek ME; Birbe R; Palazzo J; Weinberg D; Waldman SA
    Clin Cancer Res; 2006 Aug; 12(15):4545-52. PubMed ID: 16899600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanylyl cyclase C as a reliable immunohistochemical marker and its ligand Escherichia coli heat-stable enterotoxin as a potential protein-delivering vehicle for colorectal cancer cells.
    Buc E; Vartanian MD; Darcha C; Déchelotte P; Pezet D
    Eur J Cancer; 2005 Jul; 41(11):1618-27. PubMed ID: 15919201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-drug conjugate directed against the guanylyl cyclase antigen for the treatment of gastrointestinal malignancies.
    Almhanna K; Prithviraj GK; Veiby P; Kalebic T
    Pharmacol Ther; 2017 Feb; 170():8-13. PubMed ID: 27765652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potential.
    Entezari AA; Snook AE; Waldman SA
    Expert Opin Ther Targets; 2021 May; 25(5):335-346. PubMed ID: 34056991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topological mimicry and epitope duplication in the guanylyl cyclase C receptor.
    Nandi A; Suguna K; Surolia A; Visweswariah SS
    Protein Sci; 1998 Oct; 7(10):2175-83. PubMed ID: 9792105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic expression of guanylyl cyclase C in adenocarcinomas of the esophagus and stomach.
    Park J; Schulz S; Haaf J; Kairys JC; Waldman SA
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):739-44. PubMed ID: 12163327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating guanylyl cyclase C (GCC) mRNA is a reliable metastatic predictor and prognostic index of colorectal cancer.
    Jiang L; Feng JG; Wang G; Zhu YP; Ju HX; Li DC; Liu Y
    Transl Cancer Res; 2020 Mar; 9(3):1843-1850. PubMed ID: 35117531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic expression of guanylyl cyclase C in gastric cancer as a potential biomarker and therapeutic target.
    Mao ZB; Zhang JF; Xu Z; Zhu HJ; Zhang JG; Pan ZP; Xiao F; Yang JL
    J Dig Dis; 2009 Nov; 10(4):272-85. PubMed ID: 19906106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.